ÂÜÀòÂÒÂ×

Thomas Sherts is a seasoned professional in market access and strategic account management, currently serving as the National Account Director at UroGen Pharma since June 2019. Previously, Thomas held the position of Director of Market Access at Dendreon, where responsibilities included managing diverse market access channels and developing strategic initiatives. Thomas's experience also encompasses roles such as Sr. Director of Corporate Accounts at Allos Therapeutics and Reimbursement Director at Roche. Earlier in the career at GSK, Thomas progressed through various positions, including Oncology Regional Sales Director and Director of Reimbursement Strategy. Thomas Sherts earned a Bachelor of Science degree in Biology and Psychology from Grove City College from 1976 to 1980.